Condition or disease | Intervention/treatment |
---|---|
Hepatotropic Virus Infection Addictive Behaviours o Conducts Mental Disease People Sentenced to Non-custodial Sentences | Other: Observational study |
Study Type : | Observational |
Estimated Enrollment : | 1000 participants |
Observational Model: | Other |
Time Perspective: | Prospective |
Official Title: | A Novel Hepatitis c micrOelimination Program in Non imprisonEd SenTenced With Alternative Measures |
Estimated Study Start Date : | May 10, 2019 |
Estimated Primary Completion Date : | March 1, 2021 |
Estimated Study Completion Date : | March 31, 2021 |
Group/Cohort | Intervention/treatment |
---|---|
Single group of subjects who fulfill the inclusion criteria
All the population condemned to a non-custodial sentence that is presented in the Service of Management of Penalties and Alternative Measures of the Center of Social Insertion (CIS) José Hierro CP Dueso during the study period (March 2019 and March 2021) , with ages between 18 and 79 years (approximately 1000 people / year) and willing to participate (signs the IC).
|
Other: Observational study
No intervention is planned outside of usual clinical practice. Only active screening for hepatotropic virus infection, mainly hepatitis C virus, HIV, and mental illness will be carried out. If any disease is detected, patients will be referred to the corresponding specialized care following the usual clinical practice.
|
Ages Eligible for Study: | 18 Years to 79 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
Exclusion Criteria:
Contact: Antonio Cuadrado Lavín, MD | 942202544 | antonio.cuadrado@scsalud.es | |
Contact: Lucía Lavín Alconero, Bsc,PhD | 942203373 | eclinicos5@idival.org |
Spain | |
Hospital Universitario Marqués de Valdecilla | |
Santander, Cantabria, Spain, 39008 | |
Contact: Antonio Cuadrado Lavín, MD 942202544 antonio.cuadrado@scsalud.es |
Tracking Information | |||||
---|---|---|---|---|---|
First Submitted Date | April 23, 2019 | ||||
First Posted Date | April 30, 2019 | ||||
Last Update Posted Date | April 30, 2019 | ||||
Estimated Study Start Date | May 10, 2019 | ||||
Estimated Primary Completion Date | March 1, 2021 (Final data collection date for primary outcome measure) | ||||
Current Primary Outcome Measures |
|
||||
Original Primary Outcome Measures | Same as current | ||||
Change History | No Changes Posted | ||||
Current Secondary Outcome Measures | Not Provided | ||||
Original Secondary Outcome Measures | Not Provided | ||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||
Descriptive Information | |||||
Brief Title | A Novel Hepatitis c micrOelimination Program in Non imprisonEd SenTenced With Alternative Measures | ||||
Official Title | A Novel Hepatitis c micrOelimination Program in Non imprisonEd SenTenced With Alternative Measures | ||||
Brief Summary | The objective of this study is to carry out a Micro-elimination program for HCV infection in a vulnerable population (people sentenced to non-custodial sentences). This group shares certain peculiarities with the prison population (vulnerability, addictions, mental disorders, etc.), is three times higher than the imprisoned population, and is regularly attended by Social Insertion Centers (CIS) in Spain. An additional objective is to link these people with the specific plans of the Government of Cantabria (Chronicity Plan, Care for Serious Mental Disorders, Harm Reduction Programs and the Center for Attention to Drug Addicts) as well as the Extended Bridge Program for Penitentiary Institutions, implementing the figure of a Navigator (a specialized professional in charge of helping subjects overcome barriers). It is an observational study based on the screening of disease in accordance with the recommendations of the health authorities. Once detected, patients will be referred to the corresponding specialized care following the usual clinical practice. | ||||
Detailed Description | Not Provided | ||||
Study Type | Observational | ||||
Study Design | Observational Model: Other Time Perspective: Prospective |
||||
Target Follow-Up Duration | Not Provided | ||||
Biospecimen | Not Provided | ||||
Sampling Method | Non-Probability Sample | ||||
Study Population | All the population condemned to a non-custodial sentence that is presented in the Service of Management of Penalties and Alternative Measures of the Center of Social Insertion (SIC) José Hierro CP Dueso during the study period (March 2019 and March 2021) , with ages between 18 and 79 years (approximately 1000 people / year) and willing to participate (signs the IC). | ||||
Condition |
|
||||
Intervention | Other: Observational study
No intervention is planned outside of usual clinical practice. Only active screening for hepatotropic virus infection, mainly hepatitis C virus, HIV, and mental illness will be carried out. If any disease is detected, patients will be referred to the corresponding specialized care following the usual clinical practice.
|
||||
Study Groups/Cohorts | Single group of subjects who fulfill the inclusion criteria
All the population condemned to a non-custodial sentence that is presented in the Service of Management of Penalties and Alternative Measures of the Center of Social Insertion (CIS) José Hierro CP Dueso during the study period (March 2019 and March 2021) , with ages between 18 and 79 years (approximately 1000 people / year) and willing to participate (signs the IC).
Intervention: Other: Observational study
|
||||
Publications * |
|
||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status | Unknown status | ||||
Estimated Enrollment |
1000 | ||||
Original Estimated Enrollment | Same as current | ||||
Estimated Study Completion Date | March 31, 2021 | ||||
Estimated Primary Completion Date | March 1, 2021 (Final data collection date for primary outcome measure) | ||||
Eligibility Criteria |
Inclusion Criteria:
Exclusion Criteria:
|
||||
Sex/Gender |
|
||||
Ages | 18 Years to 79 Years (Adult, Older Adult) | ||||
Accepts Healthy Volunteers | No | ||||
Contacts | Contact information is only displayed when the study is recruiting subjects | ||||
Listed Location Countries | Spain | ||||
Removed Location Countries | |||||
Administrative Information | |||||
NCT Number | NCT03932396 | ||||
Other Study ID Numbers | HONEST | ||||
Has Data Monitoring Committee | No | ||||
U.S. FDA-regulated Product |
|
||||
IPD Sharing Statement | Not Provided | ||||
Responsible Party | Instituto de Investigación Marqués de Valdecilla | ||||
Study Sponsor | Instituto de Investigación Marqués de Valdecilla | ||||
Collaborators | Not Provided | ||||
Investigators | Not Provided | ||||
PRS Account | Instituto de Investigación Marqués de Valdecilla | ||||
Verification Date | April 2019 |